Published in Psychopharmacol Bull on January 01, 1997
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. J Am Acad Child Adolesc Psychiatry (2011) 2.49
Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology (2008) 1.36
Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl) (2004) 1.33
Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. Br J Clin Pharmacol (2003) 1.08
The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment. J Neurol Neurosurg Psychiatry (2001) 1.03
Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. Int J Neuropsychopharmacol (2008) 0.98
Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol (2011) 0.96
Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci (2000) 0.93
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain (2009) 0.91
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Br J Pharmacol (2001) 0.86
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations. Br J Clin Pharmacol (2014) 0.83
Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences. Psychopharmacology (Berl) (2004) 0.80
Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression. Am J Geriatr Psychiatry (2011) 0.79
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. J Pharmacokinet Pharmacodyn (2015) 0.77
Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15
Intragenic DNA spacers interrupt the ovalbumin gene. Proc Natl Acad Sci U S A (1978) 11.03
Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res (1992) 8.47
Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst (1988) 4.07
Altering genotype and phenotype by DNA-mediated gene transfer. Science (1980) 3.82
Depression, intellectual impairment, and Parkinson disease. Neurology (1981) 2.96
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A (1995) 2.92
Newer antidepressants and the cytochrome P450 system. Am J Psychiatry (1996) 2.90
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry (2000) 2.70
Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry (1996) 2.32
A 9 A resolution X-ray crystallographic map of the large ribosomal subunit. Cell (1998) 2.14
Chlamydia trachomatis: important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr (1984) 2.11
Role of RNA transcripts in replication incompatibility and copy number control in antibiotic resistance plasmid derivatives. Nature (1981) 2.05
Genes and sites involved in replication and incompatibility of an R100 plasmid derivative based on nucleotide sequence analysis. Mol Gen Genet (1980) 1.98
Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families. Neurology (1977) 1.97
Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci U S A (1989) 1.89
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
Is "subcortical dementia" a recognizable clinical entity? Ann Neurol (1983) 1.85
Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood (1994) 1.78
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A (1992) 1.77
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS (1990) 1.71
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry (1995) 1.57
Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry (1999) 1.57
Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells. Genes Dev (1989) 1.56
Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med (2000) 1.53
Site specific recombination involved in the generation of small plasmids. Mol Gen Genet (1978) 1.52
Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci U S A (1984) 1.50
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. J Clin Microbiol (1987) 1.49
Pharmacokinetic considerations of antidepressant use in the elderly. J Clin Psychiatry (1999) 1.48
Localization of postsynaptic density-93 to dendritic microtubules and interaction with microtubule-associated protein 1A. J Neurosci (1998) 1.46
Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol (2000) 1.46
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology (2000) 1.45
A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. J Clin Psychiatry (1999) 1.44
Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry (1983) 1.44
Antidepressant use over time in a rural older adult population: the MoVIES Project. J Am Geriatr Soc (1997) 1.42
Morbidity of homebound versus inpatient elderly psychiatric patients. Int Psychogeriatr (1998) 1.41
Infection with Chlamydia trachomatis: involvement of multiple anatomic sites in neonates. J Infect Dis (1979) 1.41
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med (2003) 1.39
Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology (1994) 1.39
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA (1998) 1.38
Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci U S A (1985) 1.38
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J (2003) 1.35
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry (1997) 1.34
Effect of route on inoculation on host resistance to Nocardia. Infect Immun (1980) 1.32
A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem (1991) 1.30
A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry (2001) 1.30
Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry (2000) 1.28
A brain imaging (single photon emission computerized tomography) study of semantic and affective processing in psychopaths. Biol Psychiatry (1997) 1.27
Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids. Nature (1984) 1.26
Residency training in primary care internal medicine. Report of an operational program. Ann Intern Med (1975) 1.22
Characteristics and course of major depression in older primary care patients. Int J Psychiatry Med (1998) 1.21
Gilles de la Tourette's syndrome: summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes. Adv Neurol (1976) 1.20
Comparison of Cryptosporidium parvum viability and infectivity assays following ozone treatment of oocysts. Appl Environ Microbiol (2000) 1.18
Ethical and cultural considerations in research on hereditary deafness. Otolaryngol Clin North Am (1992) 1.16
Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis. J Med Chem (2001) 1.13
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
Design of conditionally active STATs: insights into STAT activation and gene regulatory function. Mol Cell Biol (1999) 1.11
Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides. J Virol (1989) 1.10
HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. J Acquir Immune Defic Syndr (1989) 1.09
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology (1991) 1.09
Foreign body aspiration following unconventional use of a metered dose inhaler. Can J Anaesth (2000) 1.08
Mechanisms of hormonal prevention of breast cancer. Ann N Y Acad Sci (2001) 1.08
Penile advancement and lengthening in spinal cord injury patients with retracted phallus who have failed penile prosthesis placement alone. J Urol (1990) 1.07
YY1 represses beta-casein gene expression by preventing the formation of a lactation-associated complex. Mol Cell Biol (1994) 1.07
Diagnosis and management of hypochondriacal psychosis. Can Med Assoc J (1980) 1.06
Behavioral effects of sequential and one-stage ablations of orbital prefrontal cortex in the monkey. Exp Neurol (1973) 1.06
Impulsivity. J Psychopharmacol (2000) 1.05
Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation (1988) 1.04
Spontaneous renocolic fistula secondary to calculous pyonephrosis. Urology (1988) 1.03
CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock (1994) 1.03
Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J Clin Pharmacol (1995) 1.02
"Tip-of-the-tongue" phenomenon in Parkinson disease. Neurology (1982) 1.02
Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry (2001) 1.02
Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.02
Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol Immunol (1990) 1.02
Skills evaluation in minimally invasive surgery using force/torque signatures. Surg Endosc (2000) 1.02
Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry (2001) 1.01
Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol (1991) 1.00
Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry (1999) 1.00
A user-friendly instrument for rating agitation in dementia patients. Am J Geriatr Psychiatry (1994) 1.00
Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull (1996) 0.99
Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly. Depress Anxiety (2001) 0.99
Interictal memory and language impairment in temporal lobe epilepsy. Neurology (1980) 0.98
Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson's disease. J Neurol Neurosurg Psychiatry (1984) 0.98
Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. Int J Geriatr Psychiatry (1997) 0.98
Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. J Exp Med (1995) 0.97
The nucleotide sequence of the region surrounding the replication origin of an R100 resistance factor derivative. Mol Gen Genet (1979) 0.97
Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J Clin Psychopharmacol (2000) 0.97
Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology (1991) 0.97
Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. J Affect Disord (2001) 0.96